| Application no. and date | 15709212.3 (espacenet) (Federated) (European Patent Register), 20150312 | | Patent/reg. no. and date | DK/EP 3116908, 20190626 | | Publication date | 20170118 | | Priority no. and date | US 201461953035 P, 20140314 | | EP pub. no. and date |
EP 3116908 20170118 | | Effective date | | | Applicant/owner | Innate Pharma, 117, Avenue de Luminy
13009 Marseille, FR | | Applicant ref. no. | 1520811 | | Inventor | GAUTHIER, Laurent, 30 Chemin du Lancier
Résidence la Sarette Bât 8
F-13008 Marseille, FR,
SCHNEIDER, Nicolas, 78 Avenue Jules Cantini
F-13008 Marseille, FR | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 47/02 (2006.01) , A61K 47/12 (2006.01) , A61K 47/26 (2006.01) , A61K 9/00 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) | | Title | HUMANISEREDE KIR3DL2-ANTISTOFFER | | Int. application no. | EP2015055224 | | Int. publication no. | WO2015136052 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
